Stroke News and Research

RSS

A stroke is a medical emergency. Strokes happen when blood flow to your brain stops. Within minutes, brain cells begin to die. There are two kinds of stroke. The more common kind, called ischemic stroke, is caused by a blood clot that blocks or plugs a blood vessel in the brain. The other kind, called hemorrhagic stroke, is caused by a blood vessel that breaks and bleeds into the brain. "Mini-strokes" or transient ischemic attacks (TIAs), occur when the blood supply to the brain is briefly interrupted.

Magnetic resonance imaging better than computed tomography for the detection of acute stroke

Magnetic resonance imaging (MRI) is better than the more commonly used computed tomography (CT) for the detection of acute stroke, according to an Article in this week's issue of The Lancet.

28 Jan 2007

New prognostic instrument improves prediction of stroke risk after TIA

The existing prognostic scores for early-risk stroke prediction after transient ischaemic attack (TIA have been validated and refined to develop a unified score that is more predictive than previous methods, according to an Article published in this week's issue of The Lancet.

28 Jan 2007

Alteplase for appropriate stroke patients is safe and effective

The thrombolytic drug alteplase, despite recent concerns, is safe and effective in routine clinical use when used within 3 hours of stroke onset, according to an observational study published in this week's issue of The Lancet.

28 Jan 2007

Patients with acute stroke who receive stroke-unit care less likely to die

Patients with acute stroke who receive stroke-unit care are less likely to die or become disabled than patients treated in a conventional hospital ward, according to an observational follow-up study published in this week's issue of The Lancet.

28 Jan 2007

Manipulation of proliferation and differentiation of human bone marrow derived neural stem cells in vitro and in vivo

Stem cells taken from adult human bone marrow have been manipulated by scientists at the Maxine Dunitz Neurosurgical Institute at Cedars-Sinai Medical Center to generate aggregates of cells called spheres that are similar to those derived from neural stem cells of the brain.

28 Jan 2007

Neuren reports successful NNZ-2566 safety trial results

Neuren Pharmaceuticals Ltd has successfully completed a Phase 1 safety and tolerability trial of its second lead candidate, NNZ-2566, which is being developed to treat traumatic brain injury (TBI).

16 Jan 2007

Fibrinogen molecule structure acts as a molecular spring

Researchers at the University of Pennsylvania School of Medicine and the School of Arts and Sciences have shown that a well-known protein structure acts as a molecular spring, explaining one way that clots may stretch and bend under such physical stresses as blood flow.

14 Jan 2007

Stem cell research discovery could mean 'big things' for cancer

A new discovery in stem cell research may mean big things for cancer patients in the future. Gary Van Zant, Ph.D., and a research team at the University of Kentucky published their findings in Nature Genetics.

14 Jan 2007

Hospital death rate study reveals wide variations and stresses importance of Registered Nurses

Hospital death rates can be reduced by employing more Registered Nurses and the routine use of care maps or protocols, according to a study in the latest UK-based Journal of Advanced Nursing.

14 Jan 2007

Simple blood test for NT-proBNP level may help predict cardiovascular events

A blood test for patients with coronary heart disease could help predict their risk for subsequent cardiovascular events or death, according to a study in the January 10 issue of JAMA: The Journal of the American Medical Association.

9 Jan 2007

Simple blood test for the protein NT-proBNP predicts cardiac events

A simple blood test for the protein NT-proBNP accurately predicts the risk of heart attack, heart failure, stroke, and death in patients with known cardiovascular disease, according to a study led by a researcher at the San Francisco VA Medical Center.

9 Jan 2007

CleveMed receives $2.3 million in funding for inpatient diagnosis of sleep disorders in cardiovascular surgery patients

Cleveland Medical Devices has announced that it has been awarded $2.3 M in NIH SBIR Phase II Continuation funding from the National Institute of Neurological Disorders and Stroke (NINDS).

7 Jan 2007

Uric acid holds potential for central nervous system damage

Uric acid is commonly associated with the excruciatingly painful joint disease known as gout, but it can also play a crucial role in the treatment of spinal cord injury and other central nervous system disorders, such as stroke, multiple sclerosis and Parkinson's disease, according to Rutgers' Bonnie Firestein.

3 Jan 2007

Effect of vitamin supplementation on neonatal morbidity and mortality

Undernourished women who take a vitamin and mineral supplement while pregnant may be less likely than women taking only iron and folic acid supplements to have babies weighing less than 2,500 grams, and their newborns may be less likely to have morbidity in the first seven days of life.

2 Jan 2007

More Americans have their blood pressure under control

According to a new study far more Americans now have their blood pressure under control which is good news especially with regard to the risks of heart attack, stroke and other diseases.

12 Dec 2006

Research offers hope for alcoholics

Scientists at Melbourne's Howard Florey Institute have discovered a system in the brain that stops an alcoholic's craving for alcohol, as well as prevent relapse once they have recovered from alcohol addiction.

12 Dec 2006

Pfizer stops all Torcetrapib trials

On December 2, 2006, FDA was notified that Pfizer will suspend a large, Phase 3 trial evaluating the investigational cardiovascular therapy torceptrapib/atorvastatin (T/A) due to an increased rate of mortality (death) in patients receiving the combination compared to those receiving atorvastatin alone.

4 Dec 2006